Increased plasma levels of Urotensin-II in preeclampsia-eclampsia: A new mediator in pathogenesis?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 120, Issue 1, 2005, Pages 33-38

  Balat, Ozcan ^a   Aksoy, Fuat ^a   Kutlar, Irfan ^a   Ugur, Mete Gurol ^a   Iyikosker, Hakan ^b   Balat, Ayse ^a   Anarat, Rüksen ^c  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b State Hospital   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

Author keywords

Eclampsia; Preeclampsia; Pregnancy; Urotensin II

Indexed keywords

UROTENSIN II;

ADULT; ANAMNESIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ECLAMPSIA; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

EID: 18144374156     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.07.029     Document Type: Article

References (17)

1. F.G. Cunningham N.F. Gant K.J. Leveno L.C. Gilftrap III J.C. Hauth K.D. Wenstrom Hypertensive Disorders of Pregnancy 21th ed. 2001 Williams Obstetrics McGraw-Hill 567 618
2. R.K. Creasy R. Resnik Preeclampsia-Eclampsia. Maternal-Fetal Medicine 4th ed. 1999 WB Saunders Philadelphia 833 872
3. Report of The National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:1-22.
4. American College of Obstetrics and Gynecology Practice Bulletin Diagnosis and management of preeclampsia and eclampsia Obstet Gynecol 33 2002 159 167
5. J.P. Granger, B.T. Alexander, M.T. Llinas, W.A. Bennett, and R.A. Khalil Pathophysiology of preeclampsia: Linking placental ischemia/hypoxia with microvascular dysfunction Microcirculation 9 2002 147 160
6. J.J. Maguire, R.E. Kuc, and Davenport AP Orphan receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasocontrictor responses with endothelin 1 Br J Pharmacol 13 2000 441 446
7. J. Affolter, and D.J. Webb Urotensin II: a new mediator in cardiopulmonary regulation? Lancet 358 2001 774 775
8. J.J. Maguire, and A.P. Davenport Is urotensin II the new endothelin? Br J Pharmacol 137 2002 579 588
9. K. Totsune, K. Takahashi, and Z. Arihata Role of urotensin II in patients on dialysis Lancet 358 2001 810 811
10. M. Matsushita, M. Shichiri, T. Imai, M. Iwashina, H. Tanaka, and N. Takasu Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues J Hypertension 19 2001 2185 2190
11. S.A. Douglas, and E.H. Ohlstein Human urotensin II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease Trends Cardiovasc Med 10 2000 229 237
12. A.G. Gray, M.R. Jones, and I. Sharif Human urotensin II increases coronary perfusion pressure in the isolated rat heart potentiation by nitric oxide synthase and cyclooxygenase inhibition Life Sci 69 2001 175 180
13. M.R. Maclean, D. Alexander, A. Stirrat, M. Gallagher, S.A. Douglas, and E.H. Ohlstein Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat Br J Pharmacol 130 2000 201 204
14. H. Krum, and R.E. Gilbert Urothensin: a new player in vascular and myocardial disease Clin Sci 104 2003 65 67
15. F.E. Bottril, S.A. Douglas, C.R. Hiley, and R. White Human urotensin II is an endothelium dependent vasodilator in rat small arteries Br J Pharmacol 130 2000 1865 1870
16. J.T. Affolter, D.E. Newby, I.B. Wilkinson, M.J. Winter, R.J. Balment, and D.J. Webb No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans Br J Clin Pharmacol 54 2002 617 621
17. I.B. Wilkinson, J.T. Affolter, S.L. Haas, M.P. Pelligrini, J. Boyd, and M.J. Winter High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man Cardiovasc Res 53 2002 341 347